Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Apremilast improved symptoms in patients with severe skin conditions.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.